aMoon Fund

Investor type

PE / VC

Founded

2017

AUM

$750 M

Location

Ra'anana, Central District, Israel

Investment Ticket

$0-1 m

Investment Stage

Seed Series A

Region of investment

North America Europe
Investor profile last updated: 21 August, 2026

Profile

We are excited to share the first in what we expect will be an annual series of aMoon Impact reports. The purpose of this annual impact report is to share the progress our portfolio companies are making as they move along the path from innovation to commercialization to societal impact.

aMoon was founded in 2017 to seize on the rapid convergence of healthcare and technology with the mission to Accelerate Cure. We have been built from the ground-up with this goal in mind. By partnering with outstanding entrepreneurs, management teams in Israel, and other global centers of innovation, we push ourselves to advance solutions that will help people live healthier, longer, and better lives. While our mission is first and foremost about cures, we recognize that the element of time is also critical and we view ourselves as agents to help bring revolutionary ideas to life – quickly.

Industry

Biotechnology Digital Fashion/Beauty Healthcare Services Security Software MedTech Energy HealthTech Life Sciences

aMoon Fund Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
aMoon Growth
Venture Capital (VC)
Digital
Healthcare Services
Life Sciences
HealthTech
Late Stage (Series C+)
North America
Europe
Middle East
$5-10 m
$750 M
December 2018

Contacts

Name
Title
Email
avatar
Marius Nacht Co-Founder & Anchor Investor
Co-Founder & Anchor Investor
m•••@•••
avatar
Yair Schindel, MD, MBA Co-Founder & Managing Partner
Co-Founder & Managing Partner
y•••@•••
Upgrade to see contacts
avatar
FRu5VMKUL0bBPGhr FRu5VMKUL0bBPGhr
FRu5VMKUL0bBPGhr
avatar
FRu5VMKUL0bBPGhr FRu5VMKUL0bBPGhr
FRu5VMKUL0bBPGhr
avatar
FRu5VMKUL0bBPGhr FRu5VMKUL0bBPGhr
FRu5VMKUL0bBPGhr
Investment-team contacts for aMoon Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about aMoon Fund

aMoon Fund is a venture capital and private equity firm. It backs companies at Seed and Series A, writing tickets of $0-1 m.
aMoon Fund is located in Ra'anana, Central District, Israel.
aMoon Fund was founded in 2017.
aMoon Fund invests in companies and startups in Biotechnology, Digital, Fashion/Beauty, Healthcare Services, Security, Software, MedTech, Energy, HealthTech, Life Sciences.
aMoon Fund invests in companies and startups in North America, Europe.
aMoon Fund invests in companies and startups at Seed, Series A.
aMoon Fund usually invests $0-1 m on average.
aMoon Fund has around $750m assets under management.
aMoon Fund last fund was created/launched in 2018-12-11
aMoon Fund can be reached through its website amoon.fund, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for aMoon Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query aMoon Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.